The Division of Drug Information (DDI)- serving the public by providing information on human drug products and drug product regulation by FDA.
FDA's Division of Drug Information has posted new Drug Safety Podcasts for Healthcare Professionals. Click on the following links to read transcripts and listen to podcasts.
- FDA revises description of mental health side effects of stop-smoking medicines Chantix and Zyban to reflect clinical trial findings
- FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women
- Updated FDA review concludes that use of pioglitazone may be linked to an increased risk of bladder cancer